Zahedan Journal of Research in Medical Sciences

Published by: Kowsar

Androgenetic Alopecia: A Chronic or Pubertal Onset Disease Retarded by Blood Donation

Mohammad Reza Dayer 1 , * , Fatemeh Dehghani 1 , Daryush Daer 2 , Mohammad Saaid Dayer 3 and Sayed Mohammad Reza Alavi 4
Authors Information
1 Department of Biology, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, IR Iran
2 Atieh Clinic No: 122, 9th Bustan, Pasdaran, Tehran, IR Iran
3 Department of Parasitology and Medical Entomology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IR Iran
4 Department of Statistics, Faculty of Mathematics and Computer Sciences, Shahid Chamran University, Ahvaz, IR Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: September 2017, 19 (9); e10074
  • Published Online: September 30, 2017
  • Article Type: Research Article
  • Received: December 18, 2016
  • Accepted: July 22, 2017
  • DOI: 10.5812/zjrms.10074

To Cite: Dayer M R, Dehghani F, Daer D, Dayer M S, Alavi S M R. Androgenetic Alopecia: A Chronic or Pubertal Onset Disease Retarded by Blood Donation, Zahedan J Res Med Sci. 2017 ; 19(9):e10074. doi: 10.5812/zjrms.10074.

Abstract
Copyright © 2017, Zahedan Journal of Research in Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Tabolli S, Sampogna F, di Pietro C, Mannooranparampil TJ, Ribuffo M, Abeni D. Health status, coping strategies, and alexithymia in subjects with androgenetic alopecia: a questionnaire study. Am J Clin Dermatol. 2013; 14(2): 139-45[DOI][PubMed]
  • 2. Sampogna F, Tabolli S, Abeni D. Impact of different skin conditions on quality of life. G Ital Dermatol Venereol. 2013; 148(3): 255-61[PubMed]
  • 3. Rogers NE, Avram MR. Medical treatments for male and female pattern hair loss. J Am Acad Dermatol. 2008; 59(4): 547-66[DOI][PubMed]
  • 4. Randall VA. Molecular Basis of Androgenetic Alopecia. Aging Hair. 2010; : 9-24[DOI]
  • 5. Randall VA. Androgens and human hair growth. Clin Endocrinol (Oxf). 1994; 40(4): 439-57[DOI][PubMed]
  • 6. Randall VA. Hormonal regulation of hair follicles exhibits a biological paradox. Semin Cell Dev Biol. 2007; 18(2): 274-85[DOI]
  • 7. Garza LA, Yang CC, Zhao T, Blatt HB, Lee M, He H, et al. Bald scalp in men with androgenetic alopecia retains hair follicle stem cells but lacks CD200-rich and CD34-positive hair follicle progenitor cells. J Clin Invest. 2011; 121(2): 613-22[DOI][PubMed]
  • 8. Heilmann S, Nyholt DR, Brockschmidt FF, Hillmer AM, Herold C, Maan C, et al. No genetic support for a contribution of prostaglandins to the aetiology of androgenetic alopecia. Br J Dermatol. 2013; 169(1): 222-4[DOI][PubMed]
  • 9. Cobb JE, White SJ, Harrap SB, Ellis JA. Androgen receptor copy number variation and androgenetic alopecia: a case-control study. PLoS One. 2009; 4(4)[DOI][PubMed]
  • 10. Philpott M. investigations using cultured hair follicles. 2000; : 103-13[DOI]
  • 11. Randall VA, Nieschlag E, Behre HM, Nieschlag S. Testosterone: action, deficiency, substitution. 2004; : 207-32[DOI]
  • 12. Park SY, Na SY, Kim JH, Cho S, Lee JH. Iron plays a certain role in patterned hair loss. J Korean Med Sci. 2013; 28(6): 934-8[DOI][PubMed]
  • 13. Moeinvaziri M, Mansoori P, Holakooee K, Safaee Naraghi Z, Abbasi A. Iron status in diffuse telogen hair loss among women. Acta Dermatovenerol Croat. 2009; 17(4): 279-84[PubMed]
  • 14. Deloche C, Bastien P, Chadoutaud S, Galan P, Bertrais S, Hercberg S, et al. Low iron stores: a risk factor for excessive hair loss in non-menopausal women. Eur J Dermatol. 2007; 17(6): 507-12[DOI][PubMed]
  • 15. Kantor J, Kessler LJ, Brooks DG, Cotsarelis G. Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol. 2003; 121(5): 985-8[DOI][PubMed]
  • 16. Rushton DH. Nutritional factors and hair loss. Clin Exp Dermatol. 2002; 27(5): 396-404[DOI][PubMed]
  • 17. Rushton DH, Norris MJ, Dover R, Busuttil N. Causes of hair loss and the developments in hair rejuvenation. Int J Cosmet Sci. 2002; 24(1): 17-23[DOI][PubMed]
  • 18. Olsen EA, Reed KB, Cacchio PB, Caudill L. Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups. J Am Acad Dermatol. 2010; 63(6): 991-9[DOI][PubMed]
  • 19. Gonul M, Cakmak SK, Soylu S, Kilic A, Gul U. Serum vitamin B12, folate, ferritin, and iron levels in Turkish patients with alopecia areata. Indian J Dermatol Venereol Leprol. 2009; 75(5): 552[DOI][PubMed]
  • 20. Esfandiarpour I, Farajzadeh S, Abbaszadeh M. Evaluation of serum iron and ferritin levels in alopecia areata. Dermatol Online J. 2008; 14(3): 21[PubMed]
  • 21. Bregy A, Trueb RM. No association between serum ferritin levels >10 microg/l and hair loss activity in women. Dermatology. 2008; 217(1): 1-6[DOI][PubMed]
  • 22. Sinclair R. There is no clear association between low serum ferritin and chronic diffuse telogen hair loss. Br J Dermatol. 2002; 147(5): 982-4[DOI][PubMed]
  • 23. Brittenham GM. Hematology: basic principles and practice. 2000; : 397-428
  • 24. Goddard AF, James MW, McIntyre AS, Scott BB, British Society of G. Guidelines for the management of iron deficiency anaemia. Gut. 2011; 60(10): 1309-16[DOI][PubMed]
  • 25. Trost LB, Bergfeld WF, Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol. 2006; 54(5): 824-44[DOI][PubMed]
  • 26. Chandrashekar V. Do plasma cells affect hemoglobin and red blood cell counts in patients with and without myeloma? J Hematol. 2012; 1(4-5): 89-92[DOI]
  • 27. Silvestris F, Tucci M, Quatraro C, Dammacco F. Recent advances in understanding the pathogenesis of anemia in multiple myeloma. Int J Hematol. 2003; 78(2): 121-5[PubMed]
  • 28. Uebel CO, da Silva JB, Cantarelli D, Martins P. The role of platelet plasma growth factors in male pattern baldness surgery. Plast Reconstr Surg. 2006; 118(6): 1458-66[DOI][PubMed]
  • 29. Schiavone G, Raskovic D, Greco J, Abeni D. Platelet-rich plasma for androgenetic alopecia: a pilot study. Dermatol Surg. 2014; 40(9): 1010-9[DOI][PubMed]
  • 30. Fuchs E. Scratching the surface of skin development. Nature. 2007; 445(7130): 834-42[DOI][PubMed]
  • 31. Man XY, Yang XH, Cai SQ, Bu ZY, Wu XJ, Lu ZF, et al. Expression and localization of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 in human epidermal appendages: a comparison study by immunofluorescence. Clin Exp Dermatol. 2009; 34(3): 396-401[DOI][PubMed]
  • 32. Li ZJ, Choi HI, Choi DK, Sohn KC, Im M, Seo YJ, et al. Autologous platelet-rich plasma: a potential therapeutic tool for promoting hair growth. Dermatol Surg. 2012; 38(7 Pt 1): 1040-6[DOI][PubMed]
  • 33. Takikawa M, Nakamura S, Nakamura S, Ishirara M, Kishimoto S, Sasaki K, et al. Enhanced effect of platelet-rich plasma containing a new carrier on hair growth. Dermatol Surg. 2011; 37(12): 1721-9[DOI][PubMed]
  • 34. Elghetany MT, Banki K. Henry's Clinical Diagnosis and Management by Laboratory Methods. 2011; : 557-600[DOI]
  • 35. Rashid M, Ozair-Bin M, Dehghani M, Karimi M. Normal hemoglobin and hematological indices in Southwest of Iran. Iran J Blood Cancer. 2009; 1(3): 99-102
  • 36. Ramezani A, Shams M, Zarinfar N, Banifazl M, Aghakhani A, Eslamifar A, et al. Hematological reference values for healthy males in the central part of Iran. Iran J Pathol. 2014; 9(1): 50-5
  • 37. Brittenham GM. Hematology: Basic Principles and Practice. 2012;
  • 38. Farias MG, Schunck EG, Dal Bo S, de Castro SM. Definition of reference ranges for the platelet distribution width (PDW): a local need. Clin Chem Lab Med. 2010; 48(2): 255-7[DOI][PubMed]
  • 39. Fernandez KS, de Alarcon PA. Development of the hematopoietic system and disorders of hematopoiesis that present during infancy and early childhood. Pediatr Clin North Am. 2013; 60(6): 1273-89[DOI][PubMed]
  • 40. Furlan M, Lammle B. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease. Best Pract Res Clin Haematol. 2001; 14(2): 437-54[DOI][PubMed]
  • 41. Garza LA, Liu Y, Yang Z, Alagesan B, Lawson JA, Norberg SM, et al. Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia. Sci Transl Med. 2012; 4(126): 126ra34[DOI][PubMed]
  • 42. Gazi L, Gyles S, Rose J, Lees S, Allan C, Xue L, et al. Delta12-prostaglandin D2 is a potent and selective CRTH2 receptor agonist and causes activation of human eosinophils and Th2 lymphocytes. Prostaglandins Other Lipid Mediat. 2005; 75(1-4): 153-67[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments